TY  - GEN
AU  - LaMattina,John C
AU  - Mezrich,Joshua D
AU  - Hofmann,R Michael
AU  - Foley,David P
AU  - D'Alessandro,Anthony M
AU  - Sollinger,Hans W
AU  - Pirsch,John D
TI  - Alemtuzumab as compared to alternative contemporary induction regimens
SN  - 1432-2277
PY  - 2012///0802
KW  - Adult
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Antilymphocyte Serum
KW  - Basiliximab
KW  - Female
KW  - Graft Rejection
KW  - etiology
KW  - Graft Survival
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Infections
KW  - Kaplan-Meier Estimate
KW  - Kidney Transplantation
KW  - Leukopenia
KW  - Male
KW  - Middle Aged
KW  - Recombinant Fusion Proteins
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1111/j.1432-2277.2012.01448.x
ER  -